Search Results - "Ades, Anthony E"

Symptom lead time distribution in lung cancer: natural history and prospects for early diagnosis by ADES, Anthony E, BISWAS, Mousumi, WELTON, Nicky J, HAMILTON, William

“…Before their diagnosis, patients with cancer present in primary care more frequently than do matched controls. This has raised hopes that earlier investigation…”
Get full text

Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections by Blomquist, Paula B, Mighelsen, Stephanie J, Wills, Gillian, McClure, Eleanor, Ades, Anthony E, Kounali, Daphne, Dunbar, J Kevin, McClure, Myra O, Soldan, Kate, Woodhall, Sarah C, Horner, Patrick

“…Seroprevalence surveys of Chlamydia trachomatis (CT) antibodies are promising for estimating age-specific CT cumulative incidence, however accurate estimates…”
Get full text

Strategies for Efficient Computation of the Expected Value of Partial Perfect Information by Madan, Jason, Ades, Anthony E., Price, Malcolm, Maitland, Kathryn, Jemutai, Julie, Revill, Paul, Welton, Nicky J.

“…Expected value of information methods evaluate the potential health benefits that can be obtained from conducting new research to reduce uncertainty in the…”
Get full text

Correction: Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections by Blomquist, Paula B, Migchelsen, Stephanie J, Wills, Gillian, McClure, Eleanor, Ades, Anthony E, Kounali, Daphne, Dunbar, J Kevin, McClure, Myra O, Soldan, Kate, Woodhall, Sarah C, Horner, Patrick

“…[This corrects the article DOI: 10.1371/journal.pone.0208652.]…”
Get full text

Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal by Phillippo, David M., Ades, Anthony E., Dias, Sofia, Palmer, Stephen, Abrams, Keith R., Welton, Nicky J.

“…Standard methods for indirect comparisons and network meta-analysis are based on aggregate data, with the key assumption that there is no difference between…”
Get full text

Target estimands for efficient decision making: Response to comments on “Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study” by Phillippo, David M., Dias, Sofia, Ades, Anthony E., Welton, Nicky J.

Get full text

Overall Vertical Transmission of Hepatitis C Virus, Transmission Net of Clearance, and Timing of Transmission by Ades, Anthony E, Gordon, Fabiana, Scott, Karen, Collins, Intira J, Claire, Thorne, Pembrey, Lucy, Chappell, Elizabeth, Mariné-Barjoan, Eugènia, Butler, Karina, Indolfi, Giuseppe, Gibb, Diana M, Judd, Ali

“…Abstract Background It is widely accepted that the risk of hepatitis C virus (HCV) vertical transmission (VT) is 5%–6% in monoinfected women, and that 25%–40%…”
Get full text

Extrapolation of Survival Curves from Cancer Trials Using External Information by Guyot, Patricia, Ades, Anthony E., Beasley, Matthew, Lueza, Béranger, Pignon, Jean-Pierre, Welton, Nicky J.

“…Background: Estimates of life expectancy are a key input to cost-effectiveness analysis (CEA) models for cancer treatments. Due to the limited follow-up in…”
Get full text

Corrigendum to “Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine” [J Hepatol (2023) 937–946] by Hachicha-Maalej, Nadia, Collins, Intira Jeannie, Ades, Anthony E., Scott, Karen, Judd, Ali, Mostafa, Aya, Chappell, Elizabeth, Hamdy-El-Sayed, Manal, Gibb, Diana, Pett, Sarah, Mariné-Barjoan, Eugènia, Volokha, Alla, Yazdanpanah, Yazdan, Deuffic-Burban, Sylvie

Get full text

Modelling the potential effectiveness of hepatitis C screening and treatment strategies during pregnancy in Egypt and Ukraine by Hachicha-Maalej, Nadia, Collins, Intira Jeannie, Ades, Anthony E., Scott, Karen, Judd, Ali, Mostafa, Aya, Chappell, Elizabeth, Hamdy-El-Sayed, Manal, Gibb, Diana, Pett, Sarah, Mariné-Barjoan, Eugènia, Volokha, Alla, Yazdanpanah, Yazdan, Deuffic-Burban, Sylvie

“…HCV test and treat campaigns currently exclude pregnant women. Pregnancy offers a unique opportunity for HCV screening and to potentially initiate…”
Get full text

Accuracy of UK Rapid Test Consortium (UK-RTC) “AbC-19 Rapid Test” for detection of previous SARS-CoV-2 infection in key workers: test accuracy study by Mulchandani, Ranya, Jones, Hayley E, Taylor-Phillips, Sian, Shute, Justin, Perry, Keith, Jamarani, Shabnam, Brooks, Tim, Charlett, Andre, Hickman, Matthew, Oliver, Isabel, Kaptoge, Stephen, Danesh, John, Di Angelantonio, Emanuele, Ades, Anthony E, Wyllie, David H

“…AbstractObjectiveTo assess the accuracy of the AbC-19 Rapid Test lateral flow immunoassay for the detection of previous severe acute respiratory syndrome…”
Get full text

The relative responsiveness of test instruments can be estimated using a meta-analytic approach: an illustration with treatments for depression by Kounali, Daphne Z, Button, Katherine S, Lewis, Glyn, Ades, Anthony E

“…Abstract Objectives We present a meta-analytic method that combines information on treatment effects from different instruments from a network of randomized…”
Get full text

Applying Multiple Criteria Decision Analysis to Comparative Benefit-Risk Assessment: Choosing among Statins in Primary Prevention by Tervonen, Tommi, Naci, Huseyin, van Valkenhoef, Gert, Ades, Anthony E., Angelis, Aris, Hillege, Hans L., Postmus, Douwe

“…Decision makers in different health care settings need to weigh the benefits and harms of alternative treatment strategies. Such health care decisions include…”
Get full text

Modelling the potential clinical and economic impact of universal antenatal hepatitis C (HCV) screening and providing treatment for pregnant women with HCV and their infants in Egypt: a cost-effectiveness study by Hachicha-Maalej, Nadia, Lepers, Clotilde, Collins, Intira Jeannie, Mostafa, Aya, Ades, Anthony E, Judd, Ali, Scott, Karen, Gibb, Diana M, Pett, Sarah, Indolfi, Giuseppe, Yazdanpanah, Yazdan, El Sayed, Manal H, Deuffic-Burban, Sylvie

“…Backgrounds and aims Pregnant women and children are not included in Egypt’s hepatitis C virus (HCV) elimination programmes. This study assesses the…”
Get full text

Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial by Soares, Marta O, Welton, Nicky J, Harrison, David A, Peura, Piia, Shankar-Hari, Manu, Harvey, Sheila E, Madan, Jason, Ades, Anthony E, Rowan, Kathryn M, Palmer, Stephen J

“…Prior to investing in a large, multicentre randomised controlled trial (RCT), the National Institute for Health Research in the UK called for an evaluation of…”
Get full text

Accounting for Heterogeneity in Relative Treatment Effects for Use in Cost-Effectiveness Models and Value-of-Information Analyses by Welton, Nicky J., Soares, Marta O., Palmer, Stephen, Ades, Anthony E., Harrison, David, Shankar-Hari, Manu, Rowan, Kathy M.

“…Cost-effectiveness analysis (CEA) models are routinely used to inform health care policy. Key model inputs include relative effectiveness of competing…”
Get full text

Expected Value of Sample Information for Multi-Arm Cluster Randomized Trials with Binary Outcomes by Welton, Nicky J., Madan, Jason J., Caldwell, Deborah M., Peters, Tim J., Ades, Anthony E.

“…Expected value of sample information (EVSI) measures the anticipated net benefit gained from conducting new research with a specific design to add to the…”
Get full text

Indirect and mixed treatment comparisons in arthritis research by ADES, Anthony E, MADAN, Jason, WELTON, Nicky J

“…Evidence for the efficacy of biologic therapies in inflammatory arthritis comes overwhelmingly from placebo-controlled trials. Increasingly, however,…”
Get full text

Are head-to-head trials of biologics needed? The role of value of information methods in arthritis research by WELTON, Nicky J, MADAN, Jason, ADES, Anthony E

“…Reimbursement decisions are typically based on cost-effectiveness analyses. While a cost-effectiveness analysis can identify the optimum strategy, there is…”
Get full text

An overview of models used in economic analyses of biologic therapies for arthritis—from current diversity to future consensus by MADAN, Jason, ADES, Anthony E, WELTON, Nicky J

“…A number of cost-effectiveness models have been developed with the aim of providing guidance for decision making on biologic therapies for the management of…”
Get full text